Showing results (111-120 of 152) with videos related to
Sort By:
Pageof 16
Annals of Surgical Oncology|July 18, 2020
Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung CancerShinkichi Takamori, Mototsugu Shimokawa, Taichi Matsubara, et al.Anticancer Research|March 19, 2017
Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract CancerTetsuzo Tagawa, Kensaku Ito, Kengo Fukuzawa, et al.Scientific Reports|September 19, 2019
<sup>18</sup>F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancerKazuki Takada, Gouji Toyokawa, Yasuto Yoneshima, et al.Anticancer Research|May 29, 2017
Surgical Outcomes of Non-small Cell Lung Cancer in Patients with a History of Pancreaticobiliary CancerTetsuzo Tagawa, Kensaku Ito, Kengo Fukuzawa, et al.Lung Cancer (Amsterdam, Netherlands)|May 11, 2020
Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapyKazuki Takada, Shinkichi Takamori, Yasuto Yoneshima, et al.Anticancer Research|March 10, 2015
Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancerYosuke Morodomi, Tatsuro Okamoto, Mikihiro Kohno, et al.Thoracic Cancer|August 26, 2020
Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancerNobuhisa Ando, Kentaro Tanaka, Kohei Otsubo, et al.Anticancer Research|March 31, 2021
Prognostic Impact of Albumin-bilirubin (ALBI) Grade on Non-small Lung Cell Carcinoma: A Propensity-score Matched AnalysisFumihiko Kinoshita, Takanori Yamashita, Yuka Oku, et al.International Journal of Cancer|May 2, 2020
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapyShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.Journal of Cancer Research and Clinical Oncology|February 7, 2020
Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitorsKazuki Takada, Yasuto Yoneshima, Kentaro Tanaka, et al.Pageof 16